The Effect of Pseudoexfoliation on Choroidal Thickness in Open Angle Glaucoma

NCT ID: NCT03373942

Last Updated: 2017-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-08-15

Study Completion Date

2015-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: To investigate the effect of pseudoexfoliation (PEX) on choroidal thickness in primary open-angle glaucoma (POAG).

Methods: This prospective, randomized study included 30 POAG patients and 30 PEX glaucoma patients with similar demographic characteristics, and 30 eyes of 30 healthy individuals comprised the control group. Macular choroidal thickness was measured using a Cirrus HD spectral domain optical coherence tomography (OCT) instrument.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the present study, the investigators aimed to evaluate the effect of the presence of PEX on choroidal thickness in two groups of glaucoma patients with similar degrees of damage and similar demographical characteristics. The investigators also evaluated whether there was a correlation between choroidal thickness and indicators of glaucoma severity, such as retinal nerve fiber layer (RNFL) thickness and mean deviation (MD) value, in these two glaucoma types.

MATERIALS AND METHODS The study included 30 eyes of 30 patients diagnosed with POAG and 30 eyes of 30 patients diagnosed with PEX glaucoma who presented to Glaucoma Unit of Izmir Katip Celebi University Atatürk Training and Research Hospital between August 2014 and February 2015. The control group included 30 eyes of 30 healthy individuals with similar age distribution.

Approval was obtained from the ethics committee of Izmir Katip Celebi University Medical School Atatürk Training and Research Hospital. Detailed informed consent forms were obtained from each of the patients included in the study.

The study included subjects over 18 years old who had best corrected visual acuity of 0.5 or better, transparent optic medium, at least two reliable visual field tests, and reliable spectral domain (SD)-OCT (signal strength≥7/10) and EDI-OCT images (signal strength≥6/10) Information pertaining to patients' systemic diseases and chronic medication use was recorded. Patients with diabetes mellitus, systemic arterial hypertension, renal failure, hemodialysis history, chronic medication, or smoking habit were not included.

Patients with retinal and neuro-ophthalmological diseases, amblyopia, active or previous uveitis, previous ocular trauma, intraocular surgery within last 6 months, previous trabeculectomy, or refractive error with a spherical equivalent greater than ±3.0 D were excluded from the study. In order to minimize the effect of IOP on choroidal thickness, patients with IOP higher than 21 mmHg at the time of OCT image acquisition were not included in the study.

POAG was diagnosed based on high IOP (\>21 mmHg) at the time of diagnosis, typical glaucomatous optic disc and visual field changes, and normal anterior chamber angle. In contrast, PEX glaucoma diagnosis was based on high IOP (\>21 mmHg) at diagnosis and typical glaucomatous optic disc and visual field changes, plus the presence of PEX material or hyperpigmentation in the anterior chamber angle and the presence of PEX material at the pupillary margins or the anterior lens on anterior segment examination after pupil dilation. The control group consisted of healthy individuals with normal anterior and posterior segment findings and IOP less than 21 mmHg.

All subjects underwent a detailed ophthalmologic examination. Axial length was measured using IOL Master (Carl Zeiss Meditec, Dublin, CA, USA) optic biometry. Visual field was assessed with Humphrey II Perimetry (Carl Zeiss Meditec, Dublin, CA, USA) SITA standard central 24-2 test. Tests with fixation loss less than 20%, false negative, and false positive response rates below 33% were considered reliable. Patients with at least two reliable visual field tests were included in the study. MD values were obtained.

Optic disc images were obtained with Cirrus 4000 HD-OCT (Carl ZeissMeditec, Dublin, CA, USA) SD-OCT device. Mean RNFL thickness and vertical cup-to-disc (c/d) ratios were noted. Choroidal imaging was done after pupil dilation using the EDI-OCT mode. The SD Cirrus HD-OCT light source was centered on 800 nm wavelength to achieve 5 μm maximal resolution in tissue. In order to minimize the effect of diurnal choroidal thickness variation on the measurements, choroidal thickness measurements of all patients were made between 09:00 and 11:00 am, after a resting period of 30 minutes. The macular field was scanned in the horizontal plane in high-resolution 1 line raster mode. Patients were asked to focus on the instrument's internal fixation light until the retinal image was acquired. Images with signal strength of 6/10 or better were eligible for assessment. Patients who had at least two reliable high-resolution foveal and choroidal imagings were included in the study.

The fovea centralis was determined by identifying the point of maximum depression in the central 500-micron-diameter area. The internal and external choroidal margins were determined manually in the section passing through the fovea centralis. These margins were drawn based on criteria defined by Boonarpha et al.\[15\]. The posterior edge of the hyperreflective band corresponding to the retinal pigment epithelium-Bruch's membrane complex was determined as the anterior border of the choriocapillaris. The posterior border of the choriocapillaris was demarcated as the hyperreflective band corresponding to the sclerochoroidal interface or the hyporeflective line corresponding to suprachoroidal space. In cases where these two anatomic structures could not be visualized, measurement was done using the prominent straight line corresponding to the posterior margin of the large choroidal vessels. Patients in whom choroidal margins could not be clearly distinguished were not included in the study.

High-resolution retinal choroidal images with distinct choroidal margins were transferred to ImageJ software \[40\]. The high-resolution EDI-OCT images were 6000 microns wide and 2000 microns high, as indicated in the manufacturer's user's manual. EDI-OCT images to be measured were opened using ImageJ software. The Scale command was selected in the Image tab of ImageJ software menu. Using the Scale menu, width (pixels) was defined as 6000 and height (pixels) as 2000. The distance to be measured was marked on the new image of 6000x2000 pixels and measurements were done using the Measure command in Analyze tab. The choroidal margins were drawn in this software according to the specified criteria, followed by manual measurements. Measurements were taken vertically at the fovea centralis and in the nasal and temporal quadrants at distances of 1500 and 2500 microns from the fovea centralis. The same researcher repeated the measurements at different times using the double-blind method, and intraobserver and intervisit measurement repeatability was assessed.

All data were analysed using SPSS software. Independent t-test was used to compare the groups. The correlation between choroidal thickness and other variables (age, axial length, vertical c/d, RNFL thickness, MD) was evaluated using Pearson correlation analysis.Repeatability analysis of study parameters measured with Cirrus 4000 HD OCT was evaluated using the coefficient of variation (CV). For CV calculation of choroidal thickness measured by Cirrus 4000 HD OCT, 10 consequential measurements were obtained by the same operator to the same eye of the subject. CV is defined as the ratio of the standard deviation to the mean: cV=σ/μ

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma, Open-Angle

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

glaucoma EDI OCT pseudoexfoliation choroidal thickness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Primary Open Angle Glaucoma (POAG)

The study included 30 eyes of 30 patients diagnosed with POAG who presented to Glaucoma Unit of İzmir Katip Çelebi University Atatürk Training and Research Hospital

Choroidal thickness measurements with SD-OCT device

Intervention Type OTHER

Pseudoexfoliation Syndrome (PEX)

The study included 30 eyes of 30 patients diagnosed with PEX glaucoma who presented to Glaucoma Unit of İzmir Katip Çelebi University Atatürk Training and Research Hospital

Choroidal thickness measurements with SD-OCT device

Intervention Type OTHER

Control

The control group included 30 eyes of 30 healthy individuals with similar age distribution with POAG and PEX group

Choroidal thickness measurements with SD-OCT device

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Choroidal thickness measurements with SD-OCT device

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

General ophthalmological examination Visual field examination Optical biometry

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The study included subjects over 18 years old who had best corrected visual acuity of 0.5 or better, transparent optic medium, at least two reliable visual field tests, and reliable spectral domain (SD)-OCT (signal strength≥7/10) and EDI-OCT images (signal strength≥6/10)

Exclusion Criteria

* Information pertaining to patients' systemic diseases and chronic medication use was recorded. Patients with diabetes mellitus, systemic arterial hypertension, renal failure, hemodialysis history, chronic medication, or smoking habit were not included.
* Patients with retinal and neuro-ophthalmological diseases, amblyopia, active or previous uveitis, previous ocular trauma, intraocular surgery within last 6 months, previous trabeculectomy, or refractive error with a spherical equivalent greater than ±3.0 D were excluded from the study. In order to minimize the effect of IOP on choroidal thickness, patients with IOP higher than 21 mmHg at the time of OCT image acquisition were not included in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Izmir Ataturk Training and Research Hospital

OTHER

Sponsor Role collaborator

Emine Deniz Egrilmez

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emine Deniz Egrilmez

M.D.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Seyda K Ugurlu, Prof

Role: STUDY_DIRECTOR

Izmir Katip Celebi University Hospital

References

Explore related publications, articles, or registry entries linked to this study.

Anastasopoulos E, Founti P, Topouzis F. Update on pseudoexfoliation syndrome pathogenesis and associations with intraocular pressure, glaucoma and systemic diseases. Curr Opin Ophthalmol. 2015 Mar;26(2):82-9. doi: 10.1097/ICU.0000000000000132.

Reference Type BACKGROUND
PMID: 25594764 (View on PubMed)

Andrikopoulos GK, Alexopoulos DK, Gartaganis SP. Pseudoexfoliation syndrome and cardiovascular diseases. World J Cardiol. 2014 Aug 26;6(8):847-54. doi: 10.4330/wjc.v6.i8.847.

Reference Type BACKGROUND
PMID: 25228963 (View on PubMed)

Ritch R, Schlotzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001 Jan-Feb;45(4):265-315. doi: 10.1016/s0039-6257(00)00196-x.

Reference Type BACKGROUND
PMID: 11166342 (View on PubMed)

Konstas AG, Stewart WC, Stroman GA, Sine CS. Clinical presentation and initial treatment patterns in patients with exfoliation glaucoma versus primary open-angle glaucoma. Ophthalmic Surg Lasers. 1997 Feb;28(2):111-7.

Reference Type BACKGROUND
PMID: 9054481 (View on PubMed)

Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol. 2010 Sep;150(3):325-329.e1. doi: 10.1016/j.ajo.2010.04.018. Epub 2010 Jun 29.

Reference Type BACKGROUND
PMID: 20591395 (View on PubMed)

Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009 May;147(5):811-5. doi: 10.1016/j.ajo.2008.12.008. Epub 2009 Feb 20.

Reference Type BACKGROUND
PMID: 19232559 (View on PubMed)

Zhang Z, Yu M, Wang F, Dai Y, Wu Z. Choroidal Thickness and Open-Angle Glaucoma: A Meta-Analysis and Systematic Review. J Glaucoma. 2016 May;25(5):e446-54. doi: 10.1097/IJG.0000000000000275.

Reference Type RESULT
PMID: 25943737 (View on PubMed)

Bayhan HA, Bayhan SA, Can I. Evaluation of the Macular Choroidal Thickness Using Spectral Optical Coherence Tomography in Pseudoexfoliation Glaucoma. J Glaucoma. 2016 Feb;25(2):184-7. doi: 10.1097/IJG.0000000000000100.

Reference Type RESULT
PMID: 25122536 (View on PubMed)

Zengin MO, Cinar E, Karahan E, Tuncer I, Yilmaz S, Kocaturk T, Kucukerdonmez C. Choroidal thickness changes in patients with pseudoexfoliation syndrome. Int Ophthalmol. 2015 Aug;35(4):513-7. doi: 10.1007/s10792-014-9977-x. Epub 2014 Jul 25.

Reference Type RESULT
PMID: 25059402 (View on PubMed)

Goktas S, Sakarya Y, Ozcimen M, Sakarya R, Bukus A, Ivacik IS, Erdogan E. Choroidal thinning in pseudoexfoliation syndrome detected by enhanced depth imaging optical coherence tomography. Eur J Ophthalmol. 2014 Nov-Dec;24(6):879-84. doi: 10.5301/ejo.5000460. Epub 2014 Apr 4.

Reference Type RESULT
PMID: 24729143 (View on PubMed)

Eroglu FC, Asena L, Simsek C, Kal A, Yilmaz G. Evaluation of choroidal thickness using enhanced depth imaging by spectral-domain optical coherence tomography in patients with pseudoexfoliation syndrome. Eye (Lond). 2015 Jun;29(6):791-6. doi: 10.1038/eye.2015.34. Epub 2015 Mar 27.

Reference Type RESULT
PMID: 25853396 (View on PubMed)

Ozge G, Koylu MT, Mumcuoglu T, Gundogan FC, Ozgonul C, Ayyildiz O, Kucukevcilioglu M. Evaluation of retinal nerve fiber layer thickness and choroidal thickness in pseudoexfoliative glaucoma and pseudoexfoliative syndrome. Postgrad Med. 2016 May;128(4):444-8. doi: 10.1080/00325481.2016.1170579. Epub 2016 Apr 4.

Reference Type RESULT
PMID: 27007173 (View on PubMed)

Turan-Vural E, Yenerel N, Okutucu M, Yildiz E, Dikmen N. Measurement of Subfoveal Choroidal Thickness in Pseudoexfoliation Syndrome Using Enhanced Depth Imaging Optical Coherence Tomography. Ophthalmologica. 2015;233(3-4):204-8. doi: 10.1159/000371899. Epub 2015 Feb 7.

Reference Type RESULT
PMID: 25676024 (View on PubMed)

Kocabeyoglu S, Uzun S, Kadayifcilar S, Mocan MC, Irkec M. The Relationship Between Choroidal Expansion and Intraocular Pressure Rise During the Water Drinking Test in Healthy Subjects and Patients With Exfoliation Syndrome. J Glaucoma. 2016 Apr;25(4):e324-8. doi: 10.1097/IJG.0000000000000283.

Reference Type RESULT
PMID: 26035419 (View on PubMed)

Demircan S, Yilmaz U, Kucuk E, Ulusoy MD, Atas M, Gulhan A, Zararsiz G. The Effect of Pseudoexfoliation Syndrome on the Retinal Nerve Fiber Layer and Choroid Thickness. Semin Ophthalmol. 2017;32(3):341-347. doi: 10.3109/08820538.2015.1090611. Epub 2016 Apr 14.

Reference Type RESULT
PMID: 27077400 (View on PubMed)

Mwanza JC, Hochberg JT, Banitt MR, Feuer WJ, Budenz DL. Lack of association between glaucoma and macular choroidal thickness measured with enhanced depth-imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2011 May 18;52(6):3430-5. doi: 10.1167/iovs.10-6600.

Reference Type RESULT
PMID: 21357398 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

256/30.12.2015

Identifier Type: -

Identifier Source: org_study_id